Dormant
HRB · H&R Block, Inc.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 4 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Current thesis
A defended-franchise cash-return story re-rated on 2026-08-11: fiscal Q4 adjusted EPS of $2.38 beat $2.21, and the FY2027 guide of $6.04–6.24 adjusted EPS topped $5.86 consensus, with 7.9% of shares retired in FY2026 at an average $47.48 and IRS Direct File off the board. The narrative is maturing — the 2026-09-04 close of $49.06 sits 8.6% under the 52-week high with no company-dated catalyst before the early-November Q1 print.
Kill line
A weekly close below $44 (unwinds the 2026-08-11 re-rating and puts price under the $47.48 average H&R Block paid for FY2026 repurchases), or FY2027 buybacks disclosed at the ~2026-11-05 Q1 print running materially below the ~$400M plan.
Pick status
Open commitment scored if the kill line above fires How this is scored →Latest analysis and events for HRB —
As of 5 September 2026, the latest FrontierPicks analysis for H&R Block, Inc. (HRB): A defended-franchise cash-return story re-rated on 2026-08-11: fiscal Q4 adjusted EPS of $2.38 beat $2.21, and the FY2027 guide of $6.04–6.24 adjusted EPS topped $5.86 consensus, with 7.9% of shares retired in FY2026 at an average $47.48 and IRS Direct File off the board. The narrative is maturing — the 2026-09-04 close of $49.06 sits 8.6% under the 52-week high with no company-dated catalyst before the early-November Q1 print.
Kill line: A weekly close below $44 (unwinds the 2026-08-11 re-rating and puts price under the $47.48 average H&R Block paid for FY2026 repurchases), or FY2027 buybacks disclosed at the ~2026-11-05 Q1 print running materially below the ~$400M plan.
Current Thesis
The leg on offer is a defended-franchise cash-return story that re-rated in a single session. On 2026-08-11 H&R Block reported fiscal Q4 adjusted EPS of $2.38 against a $2.21 consensus and revenue of $1.145B against $1.118B, then guided fiscal 2027 above the street on both lines — revenue $4.11–4.16B versus $4.054B consensus, adjusted diluted EPS $6.04–6.24 versus $5.86. The buyer is not underwriting growth: FY2026 revenue rose 4.9% to $3.95B. The buyer is underwriting a competitor removed from the field — IRS Direct File was not offered for the 2026 filing season after Treasury ended the program in November 2025 — multiplied by a share count that fell 7.9% in FY2026, which turned that 4.9% top line into adjusted EPS of $5.31, up 13.9%.
The narrative is maturing: the story became widely known with the 2026-08-11 print and the bid behind it has thinned across the three-plus weeks since, with the 2026-09-04 close of $49.06 sitting 8.6% below the 52-week high of $53.69 and RSI(14) at 46.5. Nothing on the company calendar resolves anything before the fiscal Q1 report expected in early November.
Bullish and bearish views on H&R Block, Inc.
The model's bull view on H&R Block, Inc. (HRB), in brief: Fiscal Q4 (quarter ended 2026-06-30), reported 2026-08-11: adjusted EPS $2.38 vs $2.21 consensus; revenue $1.145B vs $1.118B consensus. The bear view: The FY2027 effective tax rate is guided to approximately 23%, against 14% in FY2026. Both cases follow in full.
Bull Case
- Fiscal Q4 (quarter ended 2026-06-30), reported 2026-08-11: adjusted EPS $2.38 vs $2.21 consensus; revenue $1.145B vs $1.118B consensus.
- FY2026 full year: revenue $3.95B (+4.9%), adjusted diluted EPS $5.31 (+13.9%), net income from continuing operations $736.3M (+20.8%), operating cash flow $838.7M (+23%).
- FY2027 guidance issued 2026-08-11 sits above prior consensus on revenue ($4.11–4.16B vs $4.054B) and adjusted EPS ($6.04–6.24 vs $5.86), with adjusted EBITDA of $1.11–1.14B.
- Capital return is doing the per-share work: FY2026 repurchases of 10.5 million shares for $500.3M at an average $47.48, retiring 7.9% of shares outstanding, with roughly $600M left of the $1.5B authorization and about $400M of repurchases planned for FY2027.
- The quarterly dividend was raised 10% to $0.46 (record 2026-09-03, payable 2026-10-06), extending the annual-increase streak to nine years.
- The structural competitive overhang was cleared before this print, not during it: Direct File's shutdown (Tax Notes and Forbes coverage, 2025-11-05) removes the free federal-filing alternative for the 2026 season and no replacement has been legislated for 2027.
Bear Case
- The FY2027 effective tax rate is guided to approximately 23%, against 14% in FY2026. A meaningful part of pre-tax progress is absorbed before it reaches the guided EPS range.
- The main EPS lever steps down. About $400M of repurchases are planned for FY2027 against $500.3M executed in FY2026, so the share-count contribution shrinks unless the pace is revisited.
- Published targets sit largely under the 2026-09-04 close of $49.06 and disagree violently: Goldman Sachs maintained a Sell on 2026-08-12 and raised its target to $33 from $29, while Barrington carries an Outperform with a $62 target; aggregator means fall in the $42–$51 band depending on the panel.
- The operating business grew 4.9% in FY2026. A 4–5% top line paired with a 23% tax rate leaves the equity dependent on buyback cadence and season-over-season pricing rather than volume.
- Reinstatement risk has not gone to zero. The "Get Your Money Back Act" (Rep. Emilia Sykes, D-Ohio) would restore Direct File; no action has been taken to date, which makes this a dormant headline rather than a dead one.
- Fiscal Q1 (September quarter) and Q2 (December quarter) are structural loss quarters. The thesis' operating evidence does not arrive until the January–April 2027 filing season.
Setup & Price Structure
- Last completed daily close 2026-09-04: $49.06. The 52-week high is $53.69, leaving price 8.6% under it. The shares are up 31.9% over three months, and RSI(14) reads 46.5 — momentum has already normalised out of the post-print thrust.
- The advance is dated. HRB appeared on Benzinga's 2026-08-12 list of large gainers alongside NBIS, CRWV and SMCI on the session after the print; third-party coverage put the post-earnings move at roughly 15–17%.
- Management's own FY2026 average repurchase price of $47.48 sits just beneath the last close, a public reference for where the company itself was a buyer through the fiscal year.
- Positioning observables, stated as observables: sell-side targets cluster below spot, with the one loud bull ($62, Barrington) and the loud bear ($33, Goldman Sachs) more than 60% apart; retail-income coverage clustered immediately ahead of the print (Benzinga, 2026-08-07, "How To Earn $500 A Month From H&R Block Stock"); there is no imminent earnings date to compress the range; no issuance into strength — share count is falling, not rising.
- No theme cluster in the registry carries this name. It is a single-name setup, and any read that leans on a group move has nothing to lean on.
- A weekly close back above $53.69 would confirm the August re-rating is extending rather than fading. A weekly close below $44 would place price under the FY2026 repurchase average and unwind the move the print created.
Catalyst Calendar (next 30 days)
- 2026-10-06 — Q1 FY2027 dividend payable at the raised $0.46 rate (record date 2026-09-03, already passed). Mechanical cash return; it confirms the raise is being paid but resolves nothing about the guide.
- Nothing else inside the window. The next company-dated event is the fiscal Q1 FY2027 report, expected ~2026-11-05 (est.) — outside 30 days. Between now and then the name trades on rate and flow, not on new company information.
- ~2027-01-26 (est.) — IRS opens the 2027 individual filing season, the first operational test of a second consecutive year without Direct File.
What Would Change Our Mind
The structure breaks if the August advance is given back before the November print can defend it — that is, if a maturing narrative with no company-dated catalyst decays into a full round-trip of the gap. The gradeable version: a weekly close below $44, which puts price under the $47.48 average H&R Block paid for its own FY2026 repurchases and erases the re-rating the 2026-08-11 guide produced.
Secondary conditions that would break the fundamental leg without a price event: FY2027 repurchases disclosed at the fiscal Q1 print running materially below the roughly $400M plan; any downward revision to the $6.04–6.24 adjusted EPS range or the ~23% tax-rate assumption; or legislative movement on the Get Your Money Back Act that puts a free federal filing product back on the 2028 board. Conversely, a fiscal Q1 print that raises the buyback plan while holding the guide would extend the leg toward the $53.69 high.
Correlation Notes
- The closest read-across is Intuit. Both incumbents benefit identically from Direct File's removal, and INTU's consumer-group commentary lands on a different fiscal clock (July year-end, late-August report), so it front-runs HRB's own season disclosures.
- HRB's June 30 fiscal year-end puts its reporting out of step with the calendar-quarter market. Its fiscal Q1 and Q2 are loss quarters by design, so the name is structurally quiet through autumn and information-dense from February to May.
- The 2026-08-12 tape had HRB moving with a broad Nasdaq rally, but the driver was the prior evening's own print. Treating the name as market-beta on that session misreads the cause.
- With no theme cluster carrying it, correlation is to rate-sensitive dividend payers and to the tax-policy headline cycle rather than to any growth complex.
Notes
- Fiscal year ends June 30. Fiscal Q1 (Sept) and Q2 (Dec) are structural loss quarters; earnings concentrate in the March and June quarters.
- Revenue is concentrated in the January–April US filing season, so a single season's volume and pricing can swing the full fiscal year.
- FY2027 effective tax rate is guided to approximately 23%, versus 14% in FY2026 — a step-up already embedded in the $6.04–6.24 EPS range.
- Quarterly dividend is $0.46 after a 10% raise announced 2026-08-11; the annual-increase streak now runs nine years.
- Roughly $600M remains of the $1.5B repurchase authorization; management planned about $400M of buybacks for FY2027.
Related · shared themes
HUM
Humana Inc.
Margin-over-volume Medicare Advantage reset is now trading on price alone: the 2026-09-03 close of $406.52 sits 0.7% under the adjusted 52-week high of $409.42, four sessions off the 08-31 close of $383.23, while the 26-desk consensus of $418.61 has not moved since 08-27 and implied upside has compressed to 2.97%. The narrative is maturing, with the ~2026-10-08 Star Ratings the next hard test.
CNC
Centene Corporation
Margin-repair leg still pressing the $68.72 52-week high — the 2026-09-03 close of $68.02 sits 1.0% under it — but nothing new has been added since the 2026-08-28 Bernstein reiteration: the $71.67 panel is static since 2026-08-23, EDGAR shows no Section 16 sale filed after 2026-08-27, and the only dated inputs before the 2026-10-27 Q3 print are the 2026-09-08 conference window and the 2026-09-30 appropriations deadline.
OSCR
Oscar Health, Inc.
A 2026-09-03 close of $32.24, +6.30% on the day and 1.6% under the 2026-08-14 closing high of $32.76, carried price above a $30.40 consensus mean that has not moved since 2026-08-25 and well above the $28.50 median. The 2026-09-16 Investor Day is the only dated event that can supply the 2027 membership and premium framework the sell side has not modelled, in a maturing narrative whose last company disclosure was 2026-08-06.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
See also · stocks to watch